Skip to content

Influence of different atomized drugs and their duration on bacterial filter resistance

Influence of atomized drugs and their duration on bacterial filter resistance and optimization of atomization scheme for severe COVID-19

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044867
Enrollment
Unknown
Registered
2021-03-30
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Novel Coronavirus Pneumonia (COVID-19), COPD, ARDS

Interventions

No atomization group:Bacterial filters are placed in the respiratory circuit
Compound ipratropium bromide solution atomization group:Bacterial filters were placed in the respiratory circuit and atomized with Compound ipratropium bromide solution
Amphotericin B atomization group:Bacterial filters were placed in the respiratory circuit and atomized with amphotericin B
Interferon atomization group:Bacterial filters were placed in the respiratory circuit and atomized with interferon

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Dec.1, 2020 solstice Admitted to intensive care unit of the First Affiliated Hospital of Guangzhou Medical University on Jan. 1, 2021. 2. The duration of mechanical ventilation was > 72 hours. 3. Use bacterial filters in the breathing loop. 4. During mechanical ventilation, they were atomized with amphotericin B, cobivent or interferon. 5.Subjects voluntarily participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Inability to tolerate or other reasons to interrupt atomization treatment in the atomization process. 2. Patient died.

Design outcomes

Secondary

MeasureTime frame
Pressure before filtering;Post-filtration pressure;Gas flow rate;

Primary

MeasureTime frame
Bacterial filter resistance;

Countries

China

Contacts

Public ContactXu Yuanda

Guangzhou Medical University

xuyuanda@sina.com+86 18928868223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026